CTRI/2022/07/044178已完成Unknown
A Proof-of-Concept, Safety and Efficacy Study for a ââ?¬Ë?Teeth Whitening Pen and PROTEETH Ultrasonic Toothbrushââ?¬â?¢ used in Combination to verify Tooth Whitening Effect and Deeper, Gentle Teeth Cleaning in Healthy Human Subjects with Tooth colour value of A2 or Darker
SkinTouch Beauty Private Limited0 个研究点目标入组 11 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 11
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Age: 18 to 65 years (both inclusive) old at the time of consent.
- •2)Ã? Sex: Healthy adult males and non-pregnant/non-lactating females.
- •3) Females of childbearing potential have a self-reported negative urine pregnancy test at the time of the screening visit and agree to follow an accepted method of birth control for the duration of the study such as condoms, foams, jellies, diaphragm, intrauterine device etc.
- •4)Ã? Subjects are generally in good general health as determined from recent medical history.
- •5)Ã? Tooth colour value of A2 or Darker (VITA scale), was determined on the middle third of the vestibular surface of the maxillary lateral incisors by the Dentist.
- •6) Subjects having 6 present upper front teeth
- •7)Ã? No previous whitening treatments
- •8)Ã? No restorations (anterosuperior group)
- •9)Ã? Anterior teeth without restorations,
- •10)No cervical lesions, or dental pain
- •11)Subjects who agree to discontinue the use of over-the-counter teeth whitening products throughout the trial.
- •12) Agree not to participate in any other oral/dental product studies during the trial.
- •13) Agree to refrain from the use of any oral care products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.).
- •14)Agree to return for all scheduled visits and follow study procedures
- •15)Subjects who are willing to complete all study procedures including study-related questionnaires and comply with study requirements.
- •16)Subjects who can read, sign, and receive a copy of Informed Consent before on of study procedures.
排除标准
- •1)Subjects who are undergoing treatment for gingivitis, periodontitis, or caries.
- •2)Subjects who have a presence of self-reported tooth sensitivity.
- •3)Subjects are present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.
- •4)Subjects have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth (canine to canine) or mandibular anterior teeth.
- •5)Subjects have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.
- •6)Subjects are present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.
- •7)Subjects have meaningful malocclusion that would impact treatment or ease of viewing/scoring maxillary anterior teeth.
- •8)Subjects have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypo calcification.
- •9)Subjects have any known allergies to over-the-counter oral hygiene/whitening products or ingredients such as hydrogen peroxide, Xanthan Gum, Citrus Limon Peel Extract, Curcuma Longa Root Extract, Menthol, Mentha Viridis, etc.
- •10)Subjects have any known allergies to the trial product ingredients.
- •11)Subjects who are current smokers.
- •12)The subject must not have participated in a clinical study with oral care or oral hygiene within 4 weeks before the screening visit of this study.
- •13) Any other condition which could warrant exclusion from the study, as per the investigatorââ?¬•s discretion.
- •14)Pregnant or breastfeeding or planning to become pregnant during the study period.
研究者
相似试验
已完成
不适用
A clinical study to assess the safety and effectiveness of Anti-Gray Hair Product in Healthy Adult Human Subjects with Partially Gray HairCTRI/2023/01/048861Anveya Living Private Limited84
尚未招募
2 期
A study using non-expanded stem cells for the treatment of early osteoarthritis of the knee (focal chondral defects) in comparison to standard conservative management.ACTRN12616001259437Cell-Innovations Pty Ltd32
进行中（未招募）
1 期
Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19)COVID-19 infection is being spread around the world with more than 400.000 cases. The spred of the disease is being a world health problem.EUCTR2020-001194-69-ESFélix Gutiérrez Rodero200
招募中
不适用
Pilot study to evaluate the efficacy and safety of MegaNuovo in Pressure sore patients : single center, comparative, investigator-initiated pilot studyDiseases of the skin and subcutaneous tissueKCT0006745Yonsei University, Wonju Severance Christian Hospital30
已完成
不适用
Pilot Study Evaluating the efficacy and safety of Polymyxin B-immobilized Fiber Column (PMX) Hemoperfusion Treatment for Idiopathic Pulmonary Fibrosis with Acute ExacerbatioIdiopathic pulmonary fibrosisJPRN-UMIN000013116ippon Medical School Hospital20